Aragon Pharmaceuticals Obtains $42,000,000 Series C Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=f44304db-9839-48df-b3c0-da8dc9787003&Preview=1 -
Date
3/6/2012 -
Company Name
Aragon Pharmaceuticals -
Mailing Address
12780 El Camino Real San Diego, CA 92130 -
Company Description
Aragon Pharmaceuticals is a San Diego based biopharmaceutical company focused on developing a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. -
Website
http://www.aragonpharmaceuticals.com -
Transaction Type
Venture Equity -
Transaction Amount
$42,000,000 -
Transaction Round
Series C -
Proceeds Purposes
This $42 million round of financing puts Aragon on strong footing to execute on its promising pipeline in prostate cancer and breast cancer. -
M&A Terms
-
Venture Investor
Topspin Partners -
Venture Investor
Aisling Capital -
Venture Investor
OrbiMed Advisors -
Venture Investor
The Column Group
